Acutaas Chemical

64
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE00FF01025
  • NSEID: ACUTAAS
  • BSEID: 543349
INR
3,438.15
122.55 (3.7%)
BSENSE

Sep 18, 03:30 PM

BSE+NSE Vol: 5.51 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
1,339.00
1,006.00
717.00
616.00
520.00
340.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1,339.00
1,006.00
717.00
616.00
520.00
340.00
Expenditure (Ex Depriciation)
Stock Adjustments
-29.00
-17.00
-28.00
-14.00
-9.00
4.00
Raw Materials Consumed
594.00
569.00
440.00
345.00
282.00
174.00
Power & Fuel Cost
37.00
30.00
25.00
22.00
21.00
5.00
Employee Cost
117.00
83.00
63.00
48.00
41.00
21.00
Operating Expenses
51.00
41.00
42.00
42.00
49.00
40.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
31.00
29.00
19.00
26.00
19.00
7.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
9.00
8.00
8.00
8.00
2.00
1.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
858.00
774.00
588.00
494.00
414.00
260.00
Operating Profit (PBDIT) excl Other Income
480.00
232.00
128.00
122.00
105.00
80.00
Other Income
41.00
16.00
7.00
4.00
2.00
1.00
Operating Profit (PBDIT)
521.00
249.00
135.00
126.00
107.00
81.00
Interest
3.00
6.00
5.00
2.00
6.00
5.00
Profit before Depriciation and Tax
518.00
242.00
130.00
124.00
101.00
75.00
Depreciation
35.00
26.00
16.00
12.00
10.00
4.00
Profit Before Taxation & Exceptional Items
482.00
216.00
113.00
112.00
91.00
71.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
482.00
216.00
81.00
112.00
91.00
71.00
Provision for Tax
126.00
55.00
33.00
28.00
19.00
17.00
Profit After Tax
356.00
160.00
48.00
83.00
71.00
53.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
453.00
307.00
275.00
203.00
131.00
97.00
Profit Available for appropriations
809.00
465.00
318.00
286.00
203.00
151.00
Appropriations
809.00
465.00
318.00
286.00
203.00
151.00
Equity Dividend (%)
50.00%
30.00%
30.00%
30.00%
30.00%
0.00%
Earnings Per Share
43.51
19.81
11.67
22.86
21.03
17.14
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 33.02% vs 40.34% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 107.00% vs 80.62% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -47.44% vs 4.68% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 122.15% vs 229.35% in Mar 2025

Compare Profit and Loss Results of Acutaas Chemical
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,339.00
1,476.00
-137.00
-9.28%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,339.00
1,476.00
-137.00
-9.28%
Expenditure (Ex Depriciation)
Stock Adjustments
-29.00
12.00
-41.00
-341.67%
Raw Materials Consumed
594.00
574.00
20.00
3.48%
Power & Fuel Cost
37.00
50.00
-13.00
-26.00%
Employee Cost
117.00
272.00
-155.00
-56.99%
Operating Expenses
51.00
112.00
-61.00
-54.46%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
31.00
23.00
8.00
34.78%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
9.00
22.00
-13.00
-59.09%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
858.00
1,153.00
-295.00
-25.59%
Operating Profit (PBDIT) excl Other Income
480.00
323.00
157.00
48.61%
Other Income
41.00
20.00
21.00
105.00%
Operating Profit (PBDIT)
521.00
343.00
178.00
51.90%
Interest
3.00
8.00
-5.00
-62.50%
Profit before Depriciation and Tax
518.00
335.00
183.00
54.63%
Depreciation
35.00
65.00
-30.00
-46.15%
Profit Before Taxation & Exceptional Items
482.00
269.00
213.00
79.18%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
482.00
346.00
136.00
39.31%
Provision for Tax
126.00
86.00
40.00
46.51%
Profit After Tax
356.00
260.00
96.00
36.92%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
453.00
752.00
-299.00
-39.76%
Profit Available for appropriations
809.00
1,012.00
-203.00
-20.06%
Appropriations
809.00
1,012.00
-203.00
-20.06%
Equity Dividend (%)
50%
120%
-70.00
Earnings Per Share
43.51
202.74
-159.23
-78.54%
Profit And Loss - Net Sales
Net Sales 1,339.37 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 33.02% vs 40.34% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 480.40 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 107.00% vs 80.62% in Mar 2025

Profit And Loss - Interest
Interest 3.27 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -47.44% vs 4.68% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 356.37 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 122.15% vs 229.35% in Mar 2025